Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline

N. J.H. van Os, N. Roeleveld, C. M.R. Weemaes, M. C.J. Jongmans, G. O. Janssens, A. M.R. Taylor, N. Hoogerbrugge, M. A.A.P. Willemsen

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

140 Citaten (Scopus)

Samenvatting

Ataxia-telangiectasia (AT) is an autosomal recessive neurodegenerative disorder with immunodeficiency and an increased risk of developing cancer, caused by mutations in the ataxia-telangiectasia mutated (ATM) gene. Logically, blood relatives may also carry a pathogenic ATM mutation. Female carriers of such a mutation have an increased risk of breast cancer. Other health risks for carriers are suspected but have never been studied systematically. Consequently, evidence-based guidelines for carriers are not available yet. We systematically analyzed all literature and found that ATM mutation carriers have a reduced life expectancy because of mortality from cancer and ischemic heart diseases (RR 1.7, 95% CI 1.2–2.4) and an increased risk of developing cancer (RR 1.5, 95% CI 0.9–2.4), in particular breast cancer (RRwomen 3.0, 95% CI 2.1–4.5), and cancers of the digestive tract. Associations between ATM heterozygosity and other health risks have been suggested, but clear evidence is lacking. Based on these results, we propose that all female carriers of 40–50 years of age and female ATM c.7271T>G mutation carriers from 25 years of age onwards be offered intensified surveillance programs for breast cancer. Furthermore, all carriers should be made aware of lifestyle factors that contribute to the development of cardiovascular diseases and diabetes.

Originele taal-2Engels
Pagina's (van-tot)105-117
Aantal pagina's13
TijdschriftClinical Genetics
Volume90
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - 1 aug. 2016
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline'. Samen vormen ze een unieke vingerafdruk.

Citeer dit